Project Scientist Series - Tinoco Lab
Open date: August 10, 2022
Next review date: Sunday, Apr 30, 2023 at 11:59pm (Pacific Time)
Apply by this date to ensure full consideration by the committee.
Final date: Wednesday, May 31, 2023 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
Project Scientist Series - Tinoco Lab
A project scientist position is available in the laboratory of Dr. Roberto Tinoco in the Department of Molecular Biology and Biochemistry in the School of Biological Sciences at the University of California, Irvine. The Tinoco lab studies the function of immune checkpoints in murine models of chronic viral infection and cancer. We are a cancer immunology and viral immunology lab. This project, funded by a grant from the NIH, will use a combination of molecular and cellular tools and conditional gene knockout mice to assess the function of T cells in virally infected hosts or in tumors. Renewal of the appointment will be contingent on the availability of adequate funding and performance. More information about our research can be found at https://www.faculty.uci.edu/profile.cfm?faculty_id=6772.
• Ph.D. in cancer biology, cell biology, immunology or a related discipline and an interest in basic viral and cancer immunology.
• MS candidate with exceptional experience may be considered upon Chancellor's approval.
• Preferred laboratory skills include cell culture, flow cytometry, molecular biology, and experience handling mice.
• Candidate will demonstrate significant, original, and creative contribution to a research or creative program or project.
For more information about this position, contact Dr. Roberto Tinoco at firstname.lastname@example.org.
Qualified candidates should submit their curriculum vitae, a cover letter, and the names and contact information of three references to the following on-line recruitment URL:
Applications will be considered until the position is filled.
The University of California, Irvine is ranked among the nation’s best universities and has robust research funding and facilities. Cancer research on campus is supported through the NCI-Designated Chao Family Comprehensive Cancer Center, and the UCI Cancer Research Institute. The Institute for Immunology supports research in this discipline. Irvine has a pleasant climate, five miles from the beach.
Accepting all applicants
Curriculum Vitae - Your most recently updated C.V.
Cover Letter (Optional)
Statement of Research (Optional)
Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.
Misc / Additional (Optional)
- 3-5 required (contact information only)
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.